Shanghai Pioneer Holding Ltd stock analysis
Want to see HK:1345 full AI Analyst Report?
Shanghai Pioneer Holding Ltd (1345) Stock Price & Analysis
1345 Stock Chart & Stats
- Day’s Range
- HKD 1.80 - HKD 1.96
- 52-Week Range
- HKD 1.35 - HKD 2.40
- Previous Close
- HKD 1.95
- Volume
- N/A
- Average Volume (3M)
- 462.63K
- Market Cap
- HKD 2.34B
- Enterprise Value
- HKD 2.63B
- Total Cash (Recent Filing)
- HKD 159.15M
- Total Debt (Recent Filing)
- HKD 218.01M
- Price to Earnings (P/E)
- 15.5
- Beta
- 0.12
- Next Earnings
- Mar 29, 2027 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- Nov 19, 2026
- Dividend Yield
- 6.15%
Bulls Say, Bears Say
Bulls Say
Conservative Balance Sheet
Very low leverage gives the company financial flexibility to withstand operating weakness, fund investments, and manage obligations without relying heavily on external financing. A strong equity base also reduces balance-sheet risk and supports resilience over the next several quarters.
Improving Free Cash Flow
Positive operating cash flow and rising free cash flow indicate that the business is currently converting operations into internally generated funding. This supports investment, debt servicing, and shareholder returns while reducing dependence on capital markets for near-term financial needs.
Healthy Product Economics
A gross margin near 49% and positive net margin show that the company retains meaningful economic value after direct costs and operating expenses. These margins provide a foundation for cash generation and leave some capacity to absorb cost pressure or reinvest in the business.
Bears Say
Declining Revenue Trajectory
The latest revenue contraction indicates weakening demand or reduced business activity, which can limit operating leverage and make future profit growth harder to achieve. Unless the top-line trend stabilizes, lower scale may constrain reinvestment and weaken the durability of earnings.
Lower Profitability And Returns
The decline in net margin and return on equity shows that the company is generating less profit and efficiency from its revenue and capital base than it did at its prior peak. Sustained weaker returns could reduce internal compounding and signal pressure on business economics.
Volatile Cash Conversion
Although recent cash generation is strong, the history of negative operating and free cash flow demonstrates uneven conversion from reported business activity into cash. Moderate obligation coverage adds financial variability, potentially limiting the reliability of funding for investment and distributions.
Shanghai Pioneer Holding Ltd News
Shanghai Pioneer Sets 2026 AGM to Approve Accounts, Board Mandates and Share Issuance Authority
Shanghai Pioneer Holding Ltd ( ($HK:1345) ) just unveiled an announcement. Shanghai Pioneer Holding Ltd has convened its annual general meeting for 22 May 2026 in Shanghai, where shareholders will
Shanghai Pioneer Holding Reshapes Board as Executive Director Resigns and New Non-Executive Joins
Shanghai Pioneer Holding Ltd ( ($HK:1345) ) just unveiled an update. Shanghai Pioneer Holding Ltd has announced a board reshuffle effective 30 March 2026, with executive director Zhang Quan resigning
Shanghai Pioneer Secures Exclusive China Rights for Labo Anti-Hair Loss Treatment
Shanghai Pioneer Holding Ltd ( ($HK:1345) ) has provided an announcement. Shanghai Pioneer Holding’s subsidiary has signed an exclusive long-term distribution agreement with Italian-based LABO INTERNATIONAL, a sister company of
1345 FAQ
What was Shanghai Pioneer Holding Ltd’s price range in the past 12 months?
What is Shanghai Pioneer Holding Ltd’s market cap?
When is Shanghai Pioneer Holding Ltd’s upcoming earnings report date?
How were Shanghai Pioneer Holding Ltd’s earnings last quarter?
Is Shanghai Pioneer Holding Ltd overvalued?
Does Shanghai Pioneer Holding Ltd pay dividends?
What is Shanghai Pioneer Holding Ltd’s EPS estimate?
How many shares outstanding does Shanghai Pioneer Holding Ltd have?
What happened to Shanghai Pioneer Holding Ltd’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Shanghai Pioneer Holding Ltd?
What is the TipRanks Smart Score and how is it calculated?
Shanghai Pioneer Holding Ltd Stock Smart Score
Company Description
Shanghai Pioneer Holding Ltd
China Pioneer Pharma Holdings Limited operates as an investment holding company, primarily focusing on the marketing, promotion, and distribution of pharmaceutical goods and medical devices within mainland China. The firm maintains an extensive portfolio of pharmaceutical products addressing diverse therapeutic areas, including ophthalmology, pain management, cardiovascular health, immunology, gynecology, and gastroenterology. Its medical device offerings encompass solutions for ophthalmology, orthopedics, dentistry, and wound care. The company supplies its products to a wide client base, including hospitals, various medical institutions, and pharmacies. Additionally, it engages in the sale of supporting tools, leases related equipment, provides dental apparatus, and distributes imported prescription products under license. Established in 1996, China Pioneer Pharma Holdings Limited is headquartered in Shanghai, PRC, and functions as a subsidiary of Pioneer Pharma (BVI) Co., Ltd.
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Yuewen Yang
- Employees
- 448
- Website
- www.pioneer-pharma.com
- Address
- No.15, Lane 88 Wuwei Road, Shanghai, SH, 200331, CN
Shanghai Pioneer Holding Ltd (1345) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 1 | 4 | 17 |
| Technical Analysis | 1 | 4 | 5 |
| Moving Averages | 0 | 0 | 12 |







